{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:40:52Z","timestamp":1791308452796,"version":"4.3.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1038\/sj.ejhg.5200883","type":"journal-article","created":{"date-parts":[[2002,12,4]],"date-time":"2002-12-04T11:58:28Z","timestamp":1039003108000},"page":"819-824","source":"Crossref","is-referenced-by-count":135,"title":["Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders"],"prefix":"10.1038","volume":"10","author":[{"given":"Bas W G","family":"van Rhijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela A G","family":"van Tilborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lurkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Bonaventure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Thiery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus H","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen C","family":"Zwarthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Radvanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,12,3]]},"reference":[{"key":"BF5200883_CR1","first-page":"1","volume":"60","author":"DE Johnson","year":"1993","unstructured":"Johnson DE, Williams LT . Structural and functional diversity in the FGF receptor multigene family Adv Cancer Res 1993 60: 1\u201341","journal-title":"Adv Cancer Res"},{"key":"BF5200883_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0168-9525(00)02021-7","volume":"16","author":"SC Robertson","year":"2000","unstructured":"Robertson SC, Tynan JA, Donoghue DJ . RTK mutations and human syndromes: when good receptors turn bad Trends Genet 2000 16: 265\u2013271","journal-title":"Trends Genet"},{"key":"BF5200883_CR3","first-page":"5206","volume":"54","author":"M Murgue","year":"1994","unstructured":"Murgue M, Tsunekawa S, Rosenberg I, deBeaumont M, Podolsky DK . Identification of a novel variant of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium Cancer Res 1994 54: 5206\u20135211","journal-title":"Cancer Res"},{"key":"BF5200883_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0925-4773(98)00133-6","volume":"77","author":"AL Delezoide","year":"1998","unstructured":"Delezoide AL, Benoist-Lasselin C, Legeai-Mallet L et al. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification Mech Dev 1998 77: 19\u201330","journal-title":"Mech Dev"},{"key":"BF5200883_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/12615","volume":"23","author":"D Cappellen","year":"1999","unstructured":"Cappellen D, De Oliveira C, Ricol D et al. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas Nat Genet 1999 23: 18\u201320","journal-title":"Nat Genet"},{"key":"BF5200883_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","volume":"14","author":"MR Passos-Bueno","year":"1999","unstructured":"Passos-Bueno MR, Wilcox WR, Jabs EW, Serti\u00e9 AL, Alonso LG, Kitoh H . Clinical spectrum of fibroblast growth factor receptor mutations Hum Mutat 1999 14: 115\u2013125","journal-title":"Hum Mutat"},{"key":"BF5200883_CR7","first-page":"23","volume":"21","author":"Z Vajo","year":"2000","unstructured":"Vajo Z, Francomano CA, Wilkin DJ . The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans Endocr Rev 2000 21: 23\u201339","journal-title":"Endocr Rev"},{"key":"BF5200883_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ng0696-233","volume":"13","author":"MC Naski","year":"1996","unstructured":"Naski MC, Wang Q, Xu J, Ornitz DM . Graded activation of fibroblast growth receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia Nat Genet 1996 13: 233\u2013237","journal-title":"Nat Genet"},{"key":"BF5200883_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0168-9525(97)01131-1","volume":"13","author":"MK Webster","year":"1997","unstructured":"Webster MK, Donoghue DJ . FGFR activation in skeletal disorders: too much of a good thing Trends Genet 1997 13: 178\u2013182","journal-title":"Trends Genet"},{"key":"BF5200883_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng0395-321","volume":"9","author":"PL Tavormina","year":"1995","unstructured":"Tavormina PL, Shiang R, Thompson LM et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 Nat Genet 1995 9: 321\u2013328","journal-title":"Nat Genet"},{"key":"BF5200883_CR11","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1086\/316892","volume":"67","author":"GA Bellus","year":"2000","unstructured":"Bellus GA, Spector EB, Speiser PW et al. Distinct missense mutations of the FGFR3 Lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype Am J Hum Genet 2000 67: 1411\u20131421","journal-title":"Am J Hum Genet"},{"key":"BF5200883_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/ng0797-260","volume":"16","author":"M Chesi","year":"1997","unstructured":"Chesi M, Nardini E, Brents LA et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 Nat Genet 1997 16: 260\u2013264","journal-title":"Nat Genet"},{"key":"BF5200883_CR13","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood.V90.10.4062","volume":"90","author":"R Richelda","year":"1997","unstructured":"Richelda R, Ronchetti D, Baldini L et al. A novel translocation t(4;14)(p16.3;q32.3) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene Blood 1997 90: 4062\u20134070","journal-title":"Blood"},{"key":"BF5200883_CR14","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood.V92.8.2987","volume":"92","author":"NS Fracchiolla","year":"1998","unstructured":"Fracchiolla NS, Luminari S, Baldini L, Lombardi L, Maiolo AT, Neri A . FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma Blood 1998 92: 2987\u20132989","journal-title":"Blood"},{"key":"BF5200883_CR15","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1038\/sj.onc.1203934","volume":"19","author":"R Wu","year":"2000","unstructured":"Wu R, Connolly D, Ngelangel C, Bosch FX, Mu\u00f1oz N, Cho KR . Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix Oncogene 2000 19: 5543\u20135546","journal-title":"Oncogene"},{"key":"BF5200883_CR16","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0002-9440(10)64665-2","volume":"158","author":"C Billerey","year":"2001","unstructured":"Billerey C, Chopin D, Aubriot-Lorton M-H et al. Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors Am J Pathol 2001 158: 1955\u20131959","journal-title":"Am J Pathol"},{"key":"BF5200883_CR17","first-page":"1265","volume":"61","author":"BWG Van Rhijn","year":"2001","unstructured":"Van Rhijn BWG, Lurkin I, Radvanyi F, Kirkels WJ, Van der Kwast ThH, Zwarthoff EC . The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate Cancer Res 2001 61: 1265\u20131268","journal-title":"Cancer Res"},{"key":"BF5200883_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/sj.onc.1204110","volume":"20","author":"K Sibley","year":"2001","unstructured":"Sibley K, Cuthbert-Heavens D, Knowles MA . Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma Oncogene 2001 20: 686\u2013691","journal-title":"Oncogene"},{"key":"BF5200883_CR19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng1295-462","volume":"11","author":"GA Meyers","year":"1995","unstructured":"Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW . Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans Nat Genet 1995 11: 462\u2013464","journal-title":"Nat Genet"},{"key":"BF5200883_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/371252a0","volume":"371","author":"F Rousseau","year":"1994","unstructured":"Rousseau F, Bonaventure J, Legeai-Mallet L et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia Nature 1994 371: 252\u2013254","journal-title":"Nature"},{"key":"BF5200883_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","volume":"787","author":"R Shiang","year":"1994","unstructured":"Shiang R, Thompson LM, Zhu YZ et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia Cell 1994 787: 335\u2013342","journal-title":"Cell"},{"key":"BF5200883_CR22","first-page":"368","volume":"56","author":"GA Bellus","year":"1995","unstructured":"Bellus GA, Hefferon TW, Ortiz de Luna RI et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3 Am J Hum Genet 1995 56: 368\u2013373","journal-title":"Am J Hum Genet"},{"key":"BF5200883_CR23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1086\/302275","volume":"64","author":"PL Tavormina","year":"1999","unstructured":"Tavormina PL, Bellus GA, Webster MK et al. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene Am J Hum Genet 1999 64: 722\u2013731","journal-title":"Am J Hum Genet"},{"key":"BF5200883_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng0795-357","volume":"10","author":"GA Bellus","year":"1995","unstructured":"Bellus GA, McIntosh I, Smith EA et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia Nat Genet 1995 10: 357\u2013359","journal-title":"Nat Genet"},{"key":"BF5200883_CR25","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/jnci\/92.24.2037","volume":"92","author":"RA Kleinerman","year":"2000","unstructured":"Kleinerman RA, Tarone RE, Abramson DH, Seddon JM, Li FP, Tucker MA . Hereditary retinoblastoma and risk of lung cancer J Natl Cancer Inst 2000 92: 2037\u20132039","journal-title":"J Natl Cancer Inst"},{"key":"BF5200883_CR26","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M","volume":"92","author":"T Kimura","year":"2001","unstructured":"Kimura T, Suzuki H, Ohashi T, Asano K, Kiyota H, Eto Y . The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas Cancer 2001 92: 2555\u20132561","journal-title":"Cancer"},{"key":"BF5200883_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1152\/physiolgenomics.2000.2.1.9","volume":"2","author":"A Winterpacht","year":"2000","unstructured":"Winterpacht A, Hilbert K, Stelzer C et al. A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia Physiol Genomics 2000 2: 9\u201312","journal-title":"Physiol Genomics"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/5200883","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5200883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5200883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T01:28:56Z","timestamp":1684373336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/5200883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["BF5200883"],"URL":"https:\/\/doi.org\/10.1038\/sj.ejhg.5200883","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}